TH Open (Apr 2019)

Autoimmune Heparin-Induced Thrombocytopenia after Transcatheter Aortic Valve Implantation: Successful Treatment with Adjunct High-Dose Intravenous Immunoglobulin

  • Tamam Bakchoul,
  • Oliver Borst,
  • Reimer Riessen,
  • Josip Lucic,
  • Meinrad Gawaz,
  • Karina Althaus,
  • Parwez Aidery

DOI
https://doi.org/10.1055/s-0039-1692990
Journal volume & issue
Vol. 03, no. 02
pp. e200 – e202

Abstract

Read online

We describe a rare case of autoimmune heparin-induced thrombocytopenia after transcatheter aortic valve implantation in which antibodies against platelet factor 4/heparin have led to platelet activation even after heparin cessation, causing a delayed drop in platelet count to below 20 × 109/L. Most interestingly, platelet count rapidly improved after intravenous immunoglobulin treatment and no new thromboembolic complications were observed with further anticoagulation with rivaroxaban.

Keywords